Condition
CHILD Syndrome
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Recruiting2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05047354Recruiting
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
NCT02383316Not ApplicableCompletedPrimary
Study of Metabolic Modifications in Children With Noonan Syndrome
NCT07248748Not ApplicableRecruitingPrimary
Effects of Alexander Technique in Children With Upper Cross Syndrome.
NCT05131542Completed
Assessment of Hypotonia in Children With Down Syndrome
NCT01110642Phase 2Withdrawn
Novel Treatment for Syndromic Ichthyoses
Showing all 5 trials